CLINICAL TRIALS PROFILE FOR DOLASETRON MESYLATE
✉ Email this page to a colleague
All Clinical Trials for dolasetron mesylate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00003817 ↗ | Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy | Completed | National Cancer Institute (NCI) | Phase 2 | 1999-10-01 | RATIONALE: Pressure or nerve stimulation applied to an acupuncture point on the inside of the wrist may help control nausea and vomiting during chemotherapy. PURPOSE: Randomized phase II trial to study the effectiveness of acupressure and acustimulation wrist bands in treating nausea and vomiting in patients undergoing chemotherapy for cancer. |
| NCT00003817 ↗ | Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy | Completed | Gary Morrow | Phase 2 | 1999-10-01 | RATIONALE: Pressure or nerve stimulation applied to an acupuncture point on the inside of the wrist may help control nausea and vomiting during chemotherapy. PURPOSE: Randomized phase II trial to study the effectiveness of acupressure and acustimulation wrist bands in treating nausea and vomiting in patients undergoing chemotherapy for cancer. |
| NCT00020657 ↗ | Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer | Completed | National Cancer Institute (NCI) | Phase 3 | 2001-07-01 | RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients being treated with chemotherapy. PURPOSE: This randomized phase III trial is comparing how well different antiemetic drugs work in preventing delayed nausea after chemotherapy in patients who have cancer. |
| NCT00020657 ↗ | Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer | Completed | Gary Morrow | Phase 3 | 2001-07-01 | RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients being treated with chemotherapy. PURPOSE: This randomized phase III trial is comparing how well different antiemetic drugs work in preventing delayed nausea after chemotherapy in patients who have cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for dolasetron mesylate
Condition Name
| Condition Name for dolasetron mesylate | |
| Intervention | Trials |
| Nausea and Vomiting | 3 |
| Unspecified Adult Solid Tumor, Protocol Specific | 2 |
| Malignant Digestive System Neoplasm | 1 |
| Postoperative Nausea and Vomiting | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for dolasetron mesylate
Trials by Country
Clinical Trial Progress for dolasetron mesylate
Clinical Trial Phase
Clinical Trial Sponsors for dolasetron mesylate
Sponsor Name
